The Living Guidelines: STEMI: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
'''For patient information click [[Heart attack (patient information)|here]]'''
'''For patient information click [[Heart attack (patient information)|here]]'''


{{WikiDoc Cardiology Network Infobox}}
 
{{CMG}}  
{{CMG}}  
__NOTOC__
__NOTOC__
'''Associate Editor:''' {{CZ}}
'''Associate Editor:''' {{CZ}}
__NOEDITSECTION__
__NOEDITSECTION__
{{Editor Join}}
 


Any recommendations found on these pages are for education use only.  Wikidoc is not a substitute for a licensed healthcare provider. Please see the [[wikidoc:General disclaimer|disclaimers]] page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. [[ACC AHA Guidelines Classification Scheme|Read more about the classification scheme used by the ACC / AHA Guidelines Committee here]].
Any recommendations found on these pages are for education use only.  Wikidoc is not a substitute for a licensed healthcare provider. Please see the [[wikidoc:General disclaimer|disclaimers]] page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. [[ACC AHA Guidelines Classification Scheme|Read more about the classification scheme used by the ACC / AHA Guidelines Committee here]].
Line 352: Line 352:
{{Circulatory system pathology}}
{{Circulatory system pathology}}
{{Electrocardiography}}
{{Electrocardiography}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Living Guidelines]]
[[Category:Living Guidelines]]
[[Category:Disease state]]
[[Category:Disease]]
[[Category:Ischemic heart diseases]]
[[Category:Ischemic heart diseases]]
[[Category:Cardiology]]
[[Category:Cardiology]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 15:28, 6 September 2012

For patient information click here


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]


Any recommendations found on these pages are for education use only. Wikidoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, Wikidoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Pharmacotherapy

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Aspirin [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Warfarin [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Beta Blocker Therapy [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for ACE Inhibitors Therapy

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Angiotensin Receptor Blockers Therapy

CLASS I [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIb [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Aldosterone Blockers Therapy

CLASS I [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System

CLASS I [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIa [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS IIb [1]

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Recommendations for Influenza Vaccination [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Reperfusion

Primary Invasive or Pharmacological Approach [1]

CLASS I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Facilitated PCI [1]

CLASS IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

CLASS III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Immediate (or Emergency) Invasive Strategy and Rescue PCI [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion [1]

Class IIb

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Anticoagulants as Ancillary Therapy [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Anticoagulants for STEMI patients who do not undergo reperfusion therapy [1]

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class III

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Thienopyridines [1]

Class I

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Class IIa

View the Current Guidelines

Click here to comment on this section of the current guidelines

Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same

Suggest Revisions to the Guidelines

Reference

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 Antman EM, Hand M, Armstrong PW; et al. (2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation. 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources